Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma

We previously identified Aurora B kinase as the only independent factor predictive of the aggressive recurrence of hepatocellular carcinoma (HCC). In this preclinical study, JNJ-28841072, a novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor, was evaluated for treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Keisuke, Tanaka, Shinji, Miura, Tomoya, Sato, Kota, Matsumura, Satoshi, Aihara, Arihiro, Mitsunori, Yusuke, Ban, Daisuke, Ochiai, Takanori, Kudo, Atsushi, Arii, Shigeki, Tanabe, Minoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556391/
https://www.ncbi.nlm.nih.gov/pubmed/26011703
http://dx.doi.org/10.1111/cas.12701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556391/
https://www.ncbi.nlm.nih.gov/pubmed/26011703
http://dx.doi.org/10.1111/cas.12701

Ejemplares similares